Immunogen (IMGN) call put ratio 22 calls to 1 put into AbbVie (ABBV) to acquire

Immunogen (NASDAQ: IMGN) December call option implied volatility is at 106, January is at 112; compared to its 52-week range of 50 to 217 into AbbVie (ABBV) to acquire ImmunoGen for $31.26 per share in cash. Call put ratio 22 calls to 1 put with focus on December 17 and January 21 calls into the bell.

You May Also Be Interested In

• Apple (AAPL) call put ratio 1.4 calls to 1 put
• Madison Square Garden Entertainment (MSGE) June 75 calls as share price near record high
• Micron Technology (MU) call put ratio 1.1 calls to 1 put as share price up 8% into quarter results